GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yidu Tech Inc (HKSE:02158) » Definitions » Sloan Ratio %

Yidu Tech (HKSE:02158) Sloan Ratio % : -2.55% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Yidu Tech Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Yidu Tech's Sloan Ratio for the quarter that ended in Sep. 2023 was -2.55%.

Warning Sign:

When sloan ratio (42.13)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Sep. 2023, Yidu Tech has a Sloan Ratio of -2.55%, indicating the company is in the safe zone and there is no funny business with accruals.


Yidu Tech Sloan Ratio % Historical Data

The historical data trend for Yidu Tech's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yidu Tech Sloan Ratio % Chart

Yidu Tech Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Sloan Ratio %
Get a 7-Day Free Trial -40.20 -99.10 9.63 -74.83 42.13

Yidu Tech Semi-Annual Data
Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only -46.34 -72.93 59.04 41.29 -2.55

Competitive Comparison of Yidu Tech's Sloan Ratio %

For the Health Information Services subindustry, Yidu Tech's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yidu Tech's Sloan Ratio % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Yidu Tech's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Yidu Tech's Sloan Ratio % falls into.



Yidu Tech Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Yidu Tech's Sloan Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Sloan Ratio=(Net Income (A: Mar. 2023 )-Cash Flow from Operations (A: Mar. 2023 )
-Cash Flow from Investing (A: Mar. 2023 ))/Total Assets (A: Mar. 2023 )
=(-715.25--406.636
--2665.543)/5594.183
=42.13%

Yidu Tech's Sloan Ratio for the quarter that ended in Sep. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Sep. 2023 )
=(-393.874--447.186
-186.416)/5211.718
=-2.55%

For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data. Yidu Tech's Net Income for the trailing twelve months (TTM) ended in Sep. 2023 was -312.596 (Mar. 2023 ) + -81.278 (Sep. 2023 ) = HK$-393.9 Mil.
Yidu Tech's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2023 was -135.613 (Mar. 2023 ) + -311.573 (Sep. 2023 ) = HK$-447.2 Mil.
Yidu Tech's Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2023 was 36.582 (Mar. 2023 ) + 149.834 (Sep. 2023 ) = HK$186.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yidu Tech  (HKSE:02158) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Sep. 2023, Yidu Tech has a Sloan Ratio of -2.55%, indicating the company is in the safe zone and there is no funny business with accruals.


Yidu Tech Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Yidu Tech's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Yidu Tech (HKSE:02158) Business Description

Traded in Other Exchanges
Address
No.9 Building of Huayuan North Road, 8th Floor Health Work, Haidian District, Beijing, CHN
Yidu Tech offers healthcare Big Data. It is an AI cloud-based firm providing solutions and tools to aid in more informed decisions to drive better efficiency in clients' strategies. Its clients are hospitals, pharmaceutical, biotech and medical device firms, research institutions, insurance companies, patients, and regulators. It three business segments are: Big Data platform and solutions, which partners with hospitals and policymakers to drive better efficiency; life sciences solutions, which enables better probability of clinical trial success with less drug development time and cost; and health management solutions, which helps with patient management. The Big Data platform accounted for 33% of revenue, life science solutions 30%, and health management solutions 27%, in fiscal 2022.
Executives
Gong Yingying 2202 Interest of your spouse
Xu Jiming 2101 Beneficial owner
Brunei Investment Agency 2101 Beneficial owner
Gic Private Limited 2102 Investment manager
Sweet Panda Limited 2101 Beneficial owner

Yidu Tech (HKSE:02158) Headlines

No Headlines